Table 2.

Outcomes of patients with CISR after a minimum follow-up of 12 months

Outcomes	N (%)
Primary outcome* (MACE)	18 (16.4)
Nonfatal AMI	13 (11.8)
Q AMI	4
Non-Q AMI	9
Cardiovascular death	6(5.5)
Secondary outcome†	24 (21.8)
TVR	11 (10)
TLR	3 (2.7)
TVR -TLR	11 (10)
Unstable angina with readmission	13 (11.8)

^*The total number of individual primary outcomes was 19: 18 patients had a single event and one patient had two events.

^†The total number of individual secondary outcomes was 27: three patients had two events, TVR and TLR. Qualitative variables are presented as number (%). CISR: clinical in-stent restenosis; MACE: major cardiac events; AMI: acute myocardial infarction; Q AMI: Q acute myocardial infarction; Non-Q AMI: non-Q acute myocardial infarction; TLR: target lesion revascularization; TVR: target vessel revascularization; TVR + TLR: target vessel revascularization + target lesion revascularization.